DKSH has entered an agreement with Foxx Life Science in Asia. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific Instrumentation market.
Bangkok, December 28, 2021– DKSH Business Unit Technology has entered a partnership with Foxx Life Sciences, a global leader offering a wide range of products for life science, biotech, pharmaceutical and diagnostic research. DKSH will provide sales, marketing, and after-sales services in Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, and Vietnam.
Foxx Life Sciences offers a wide selection of products including Laboratory and Bioprocess Single-Use Systems (SUS) including tubing, sterile and non-sterile bottles, flask and carboys, filtration, fluid management, and laboratory safety products. DKSH will help promote Foxx Life Sciences’ range of products to customers in the Biotech, Biopharma, Accademia, and Research industries with a focus on research, QA/QC and bioprocessing applications.
“DKSH offers good market coverage and in-depth industry knowledge. We believe that DKSH is the right partner to help us expand the market in APAC and meet our aggressive growth goals,” said Mark Robillard, Senior Vice President Global Sales and Business Development, Foxx Life Sciences.
Marco Farina Senior Director, Business Development, Business Unit Technology, commented: “With the partnership with Foxx Life Sciences, DKSH has gained access to a wide range of consumable for life science and biopharma. We are excited to introduce Foxx Life Sciences’ leading products to our customers and we are confident to grow the market leveraging our good sales coverage and strong application support.”
About Foxx Life Sciences
Located just 32 miles north of Boston in Londonderry, NH, Foxx Life Sciences is a privately held, global leader in developing, manufacturing, and delivering an extensive range of high-quality products for life science, biotech, pharmaceutical and diagnostic research. The company has been ISO 13485 certified for 11 years in a row and is an FDA Registered company.
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Technology offers complete solutions for specialized industrial applications. With around 1,540 specialists, the Business Unit generated net sales of CHF 382.5 million in 2020. www.dksh.com/tec